Reviewed by Chaitra Ujjani, MD, Associate Professor, Division of Medical Oncology, Seattle Cancer Care Alliance, Seattle, Washington Patients with follicular lymphoma (FL) who experience progression ...

Chemotherapy is the primary treatment for non-Hodgkin lymphoma, though people may also receive it with immunotherapy. Chemotherapy remains the first-line treatment for non-Hodgkin lymphoma (NHL), a ...

Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL). Telomere profile of Reed-Sternberg and Hodgkin cells in diagnostic biopsy in Hodgkin ...

Leveraging Implementation Science to Optimize Strategies for Cancer Control in Mexico and Latin America We enrolled 55 patients with low grade lymphoma. Median age was 58 (range 28-82), 35 (64%) were ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular ...

Reduced doses of radiation were shown to be effective for some patients with indolent orbital B-cell lymphoma, researchers said. Ultralow-dose radiation therapy is an effective treatment strategy for ...

In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...

Investigators postulated that combined modality treatment might improve long-term outcomes for patients with early-stage follicular lymphoma. The systemic therapy component would have to block occult ...

In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a ...